Aviva PLC Has $949,000 Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Aviva PLC reduced its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Rating) by 41.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 11,712 shares of the company’s stock after selling 8,300 shares during the period. Aviva PLC’s holdings in U.S. Physical Therapy were worth $949,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. lifted its stake in U.S. Physical Therapy by 1.1% in the 1st quarter. BlackRock Inc. now owns 2,076,064 shares of the company’s stock valued at $206,466,000 after acquiring an additional 22,653 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in U.S. Physical Therapy by 2.1% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,542,130 shares of the company’s stock worth $117,233,000 after purchasing an additional 31,732 shares during the last quarter. Vanguard Group Inc. grew its position in U.S. Physical Therapy by 1.1% in the first quarter. Vanguard Group Inc. now owns 927,480 shares of the company’s stock valued at $92,238,000 after purchasing an additional 10,015 shares in the last quarter. Copeland Capital Management LLC increased its stake in U.S. Physical Therapy by 24.6% in the 4th quarter. Copeland Capital Management LLC now owns 603,165 shares of the company’s stock valued at $48,874,000 after buying an additional 119,201 shares during the last quarter. Finally, Eaton Vance Management lifted its position in U.S. Physical Therapy by 1.9% during the 3rd quarter. Eaton Vance Management now owns 567,390 shares of the company’s stock worth $43,133,000 after buying an additional 10,557 shares in the last quarter. Institutional investors own 98.44% of the company’s stock.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 471 shares of the stock in a transaction dated Monday, March 13th. The shares were sold at an average price of $95.80, for a total value of $45,121.80. Following the transaction, the chief financial officer now directly owns 14,886 shares of the company’s stock, valued at approximately $1,426,078.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CFO Carey P. Hendrickson sold 471 shares of the business’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $95.80, for a total value of $45,121.80. Following the completion of the sale, the chief financial officer now directly owns 14,886 shares in the company, valued at approximately $1,426,078.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Richard Binstein sold 911 shares of the stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $100.78, for a total value of $91,810.58. Following the transaction, the executive vice president now owns 9,906 shares in the company, valued at approximately $998,326.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,814 shares of company stock worth $484,853. 1.80% of the stock is owned by insiders.

Analysts Set New Price Targets

USPH has been the topic of a number of recent research reports. Barrington Research lifted their target price on U.S. Physical Therapy from $110.00 to $116.00 in a research report on Friday, May 5th. TheStreet upgraded U.S. Physical Therapy from a “c+” rating to a “b-” rating in a research note on Friday, May 5th. Finally, StockNews.com assumed coverage on shares of U.S. Physical Therapy in a research note on Thursday. They issued a “hold” rating for the company.

U.S. Physical Therapy Trading Up 1.4 %

Shares of NYSE:USPH opened at $113.87 on Monday. U.S. Physical Therapy, Inc. has a 52-week low of $73.30 and a 52-week high of $131.50. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.30 and a current ratio of 1.30. The company has a market capitalization of $1.49 billion, a P/E ratio of 52.72, a price-to-earnings-growth ratio of 4.34 and a beta of 1.35. The company has a 50-day simple moving average of $102.86 and a 200 day simple moving average of $94.87.

U.S. Physical Therapy (NYSE:USPH – Get Rating) last released its quarterly earnings data on Wednesday, May 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. The company had revenue of $148.51 million during the quarter, compared to analysts’ expectations of $140.77 million. U.S. Physical Therapy had a return on equity of 10.93% and a net margin of 5.40%. The business’s revenue was up 12.8% on a year-over-year basis. During the same period last year, the firm posted $0.65 earnings per share. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.63 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 9th. Stockholders of record on Thursday, May 18th will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.51%. The ex-dividend date of this dividend is Wednesday, May 17th. U.S. Physical Therapy’s payout ratio is presently 79.63%.

U.S. Physical Therapy Company Profile

(Get Rating)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services.